Quest Diagnostics, a medical laboratories firm, reported an agreement with OMERS to buy LifeLabs, a provider of community laboratory tests for a huge number of Canadians, for a worth of around CAN $1.35 billion (around USD $985 million), including...
AstraZeneca India Private Limited (AZIPL), the British-Swedish drugmaker's global capabilities center (GCC), has announced a Rs 250 crore ($30 million) investment to expand its Global Innovation and Technology center (GITC) in...
Ipsen, a worldwide biopharmaceutical firm with an emphasis on getting groundbreaking medicines to patients in three remedial regions: oncology, interesting sickness and neuroscience, has reported confirmation of an extended partnership and license...
Bone Health Technologies (BHT), a leading medtech innovator developing breakthrough noninvasive and drug-free solutions for low bone density, announced the company has been awarded a fifth patent for Osteoboost—the first and only FDA-cleared...
Sanofi and Regeneron received European Union permission for the expanded use of their Dupixent injection in patients with chronic lung disease, a rare instance of the EU clearing a medicine faster than the United States. The EU Commission...
Sobi declared the commencement of a rolling Biologics License Application (BLA) to the US Food and Drug Administration (FDA) for SEL-212. The pivotal studies DISSOLVE I and II served as the foundation for the submission. For the treatment of...
Kedrion Biopharma Inc., a biopharmaceutical firm, declared that it has established the framework for a long-term partnership with Biotest AG for the complete commercialization and marketing of the immunoglobulin therapy Yimmugo in the United...
PharmAbcine, Inc, a clinical-stage firm developing next generation therapeutics to treat medical needs, declared the decision to accelerate PMC-403, its candidate treatment for neovascular age-related macular degeneration (nAMD), to the fourth...
Synaptogenix, Inc., a growing biopharmaceutical firm developing therapies for neurodegenerative disorders, announced that the Food and Drug Administration (FDA) has approved an Investigational New Drug (IND) application for Bryostatin-1...
The Government of Kerala has decided to establish an Institute of Organ and Tissue Transplant at Kozhikode. It is being established as an Apex Institute for research, training and patient care in the area of organ transplantation and allied
, CDSCO.jpg)
